about
Progesterone receptor modulates ERα action in breast cancer.Pushing estrogen receptor around in breast cancerDeciphering the divergent roles of progestogens in breast cancer.Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotypeExpression and localisation of c-kit and KITL in the adult human ovary.Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors.Regulators of genetic risk of breast cancer identified by integrative network analysis.Expression of androgen receptor splice variants in clinical breast cancers.Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries.Complexities of androgen receptor signalling in breast cancer.Bringing androgens up a NOTCH in breast cancer.Androgens induce divergent proliferative responses in human breast cancer cell lines.Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation.Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.Mouse GDF9 decreases KITL gene expression in human granulosa cells.Identification of androgen receptor splice variant transcripts in breast cancer cell lines and human tissues.Androgens augment the mitogenic effects of oocyte-secreted factors and growth differentiation factor 9 on porcine granulosa cells.Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate Cancer.Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results.The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome.Improved relapse-free survival on aromatase inhibitors in breast cancer is associated with interaction between oestrogen receptor-α and progesterone receptor-bA patient-derived explant (PDE) model of hormone-dependent cancerErratum: Corrigendum: Progesterone receptor modulates ERα action in breast cancerPolycystic ovary syndromeEpigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndromeBiomarkers: Polycystic ovary syndrome: steroid assessment for diagnosisNon-canonical AR activity facilitates endocrine resistance in breast cancerAndrogen Receptor Signalling Promotes a Luminal Phenotype in Mammary Epithelial CellsAnti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptorInterplay between the androgen receptor signaling axis and microRNAs in prostate cancerPatient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response
P50
Q27316268-886B8C76-D2AE-474F-9CA5-0AE93E9C3758Q28079866-17518F97-AB6A-4181-9A9B-DAC98BECF9C3Q30240711-F2544F0F-5A33-449D-A25C-7E1A4F406AD8Q33733903-EA081326-1D73-465C-9920-4BA0447FD2FCQ35700376-C30C0128-0736-4381-92C5-398E1E3256E6Q36113793-5DFD8103-EC3B-4864-97CC-B4598BE8CCB7Q36130090-5608A2CA-FD85-412B-8FB7-A10FD736DA76Q36419747-24444509-D4FF-4AA1-9107-5B900D4F4E40Q36689084-BAF58B08-4A06-44A2-811C-6CB9AAEB706FQ37056109-AB4FC116-E4FD-4F83-86EC-387ADC7229CDQ37419236-2013EE55-57F9-4BE0-B99A-0096EEDADE0FQ38222027-2AC27D08-BF32-48CF-96DE-ACF0874CADC2Q38227009-46C21AF8-6CC7-420A-BA2B-B69BF510F081Q38295844-87D5A01A-678C-4B28-8813-BDB9249C8AB4Q38590446-9EF9F2C8-8049-4900-842F-B1ACC1C8BDC6Q38753546-69F984A0-2234-4364-B20C-3C5AB6270A65Q38979009-272D4AD5-359F-4131-9961-03D77E173D3BQ39020826-BF93CC1F-79CD-4530-B28A-FC91447E6C52Q46562079-36D1D34B-DD53-47DF-8CF9-0BADF62C437AQ51019461-D5E4E8E0-C159-4B24-A188-BBD3F2A57F12Q51406329-79A72384-1E3C-4262-9319-63BB32F8DF2EQ52668715-46A976C9-0042-4CEE-93E5-BF9CE2DC5236Q58561637-C5C362C2-1A9B-49E1-A97B-503DDBA5FE70Q58772979-428486C4-1F92-4E70-8537-6CD8A24ECD42Q59082689-8E6962B3-A6E5-47F5-9C66-37F093CF2573Q80844876-55C56F1E-2CE7-4E97-B47A-D380B9D3FA57Q83195039-98940FA8-377E-4AD7-93A7-6BDE483362CEQ84301558-85159264-AB6D-4D09-B782-F50F7E76B0BDQ90587388-20BD0374-2F58-4CAD-A8F4-073D1A378442Q90900248-B1BF0182-E371-48DA-81D3-214C3AE379D6Q91724701-42F87036-593A-4B8F-AED3-945C3DBCF093Q92004528-9535BAD9-07E3-46B3-A7CB-8AFFEBFF3D37Q93361099-CC90E7B5-F004-4C42-B545-C60D30D6F7AD
P50
description
researcher ORCID ID = 0000-0002-2752-730X
@en
wetenschapper
@nl
name
Theresa E Hickey
@ast
Theresa E Hickey
@en
Theresa E Hickey
@nl
type
label
Theresa E Hickey
@ast
Theresa E Hickey
@en
Theresa E Hickey
@nl
prefLabel
Theresa E Hickey
@ast
Theresa E Hickey
@en
Theresa E Hickey
@nl
P21
P31
P496
0000-0002-2752-730X